Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for ADHD in Neurofibromatosis Type 1
NCT00169611Phase 4Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2004
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Simplified Parents Conners' Rating Scale at Day 63. Started Jan 2004; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00169611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169611.